BBIO vs SBUX · rev $438.2M vs P/E 76, rev $37.18B
BridgeBio Pharma Inc (BBIO) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian Niccol.
Latest reported BBIO revenue for 2026-06-30 was $438.2M. Net income was -$322.4M. BBIO currently screens at market cap $13.24B.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
BBIO currently screens at market cap $13.24B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the BBIO and SBUX stock pages for the full models.
Not investment advice.